Terumo To Accelerate Product Development And Expand Home Healthcare Market In Japan
This article was originally published in PharmAsia News
Executive Summary
Japanese medical device maker Terumo plans to develop new products and strengthen its home oxygen therapeutic business. The company will accelerate commercializing compact and efficient oxygen condensing devices used in home intravenous therapies. In Japan, Terumo accounts for 10 percent of the home oxygen therapeutic market and 90 percent of the home intravenous therapy market. The company is focusing in Tokyo, central Japan and the Kansai area. Patients in other areas are covered through agents or local dealers. Terumo aims to increase annual sales from an estimated ¥4.3 billion in 2009 to ¥18 billion within ten years. (Click here for more - Japanese language
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.